Daniel M Geynisman
10PUBLICATIONS
147CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.Andrea Necchi, Matthew D Galsky, Nazli Dizman
|Jan 06, 2025
Treatment Patterns and Costs Among Patients With Metastatic Renal Cell Carcinoma in the United States: A Real-World Study Using Integrated Claims and Clinical Data.Daniel M Geynisman, Nathan R Hill, Lisa C Rosenblatt
|Dec 16, 2024
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).Daniel M Geynisman, Philip H Abbosh, Eric Ross
|Jun 12, 2024
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates.Uttam Satyal, Henkel Valentine, David Liu
|May 15, 2024
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort Evaluation.Laura Bukavina, Rashida Ginwala, Mohamed Eltoukhi
|Jun 27, 2023
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak
Pageof 2
Frequent Collaborators
5 joint publications
Elizabeth R Plimack
3 joint publications
Philip H Abbosh
3 joint publications
Eric Ross
3 joint publications
Philippe E Spiess
3 joint publications
Matthew R Zibelman
2 joint publications
Samuel U Takvorian
2 joint publications
Daniel Vader
2 joint publications
Gaurav Goyal
2 joint publications
Gabrielle B Rocque
2 joint publications
Pooja Phull
